Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 31 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 85% of rolling 1-year windows.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.46% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -14.4%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 50.6% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 14%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
7 Jan 2026 – 21 Apr 2026
Trough 30 Mar 2026 · recovered in 22 days
-14.4%
10 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-11.9%
24 Mar 2025 – 16 Apr 2025
Trough 7 Apr 2025 · recovered in 9 days
-6.4%
23 Apr 2025 – 15 May 2025
Trough 9 May 2025 · recovered in 6 days
-5.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
17
Vs category
50
Consistency
85
Risk-adjusted
42
Drawdown
64
Mean
52
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
30 Sept 2026 · 52 holdings · top 10 are 50.6%.
Reverse Repo
Unspecified
15.0%
Divi's Laboratories Ltd
Healthcare
5.5%
TVS Motor Company Ltd
Consumer Discretionary
4.5%
Hindustan Aeronautics Ltd
Industrials
4.1%
Tata Motors Ltd
Industrials
4.1%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
22 Sept 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Edelweiss Mutual Fund
Kotak Mahindra Mutual Fund
Nippon India Mutual Fund
ICICI Prudential Mutual Fund
Caveat: Deeper drawdown
Aditya Birla Sun Life Mutual Fund
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 31 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 85% of rolling 1-year windows.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Fail
1.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.46% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -14.4%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 50.6% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 14%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
31 Oct 2026 · -2.5% over 1Y
11.9612
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
31 Oct 2026
-9.4%
7 Jan 2026 – 21 Apr 2026
Trough 30 Mar 2026 · recovered in 22 days
-14.4%
10 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-11.9%
24 Mar 2025 – 16 Apr 2025
Trough 7 Apr 2025 · recovered in 9 days
-6.4%
23 Apr 2025 – 15 May 2025
Trough 9 May 2025 · recovered in 6 days
-5.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
17
Vs category
50
Consistency
85
Risk-adjusted
42
Drawdown
64
Mean
52
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
Supporting reads
30 Sept 2026 · 52 holdings · top 10 are 50.6%.
Reverse Repo
Unspecified
15.0%
Divi's Laboratories Ltd
Healthcare
5.5%
TVS Motor Company Ltd
Consumer Discretionary
4.5%
Hindustan Aeronautics Ltd
Industrials
4.1%
Tata Motors Ltd
Industrials
4.1%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
24 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
23 Sept 2026
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
22 Sept 2026
DECISION
Status moved from HEALTHY to MONITOR.
22 Sept 2026